Page last updated: 2024-10-18

dalteparin and Adenocarcinoma, Bronchiolo-Alveolar

dalteparin has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Adenocarcinoma, Bronchiolo-Alveolar: A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colagiovanni, A1
Rizzi, A1
Buonomo, A1
De Pasquale, T1
Pecora, V1
Sabato, V1
Aruanno, A1
Pascolini, L1
Nucera, E1
Schiavino, D1

Other Studies

1 other study available for dalteparin and Adenocarcinoma, Bronchiolo-Alveolar

ArticleYear
Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested.
    Contact dermatitis, 2010, Volume: 63, Issue:2

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Anticoagulants; Breast Neoplasms; Drug

2010